Animal Healthcare Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
Market Report I 2026-03-11 I 143 Pages I Global Market Insights
The Global Animal Healthcare Market was valued at USD 220.8 billion in 2025 and is estimated to grow at a CAGR of 5.9% to reach USD 399.4 billion by 2035.
Market growth is influenced by the increasing occurrence of animal diseases, including both long-term health conditions and infectious illnesses that require advanced veterinary care. The rising interaction between humans and animals across agricultural settings, residential environments, and urban ecosystems has also elevated the importance of effective animal health management. The animal healthcare market encompasses a broad global industry dedicated to preventing, diagnosing, and treating medical conditions affecting both companion animals and livestock populations. It includes veterinary pharmaceuticals, vaccines, diagnostic solutions, medicated feed additives, medical equipment, and disposable supplies designed to protect animal health and support livestock productivity. In addition, improved disease control helps safeguard public health by reducing the risk of zoonotic disease transmission. The industry is gradually shifting away from generalized treatment methods toward more advanced preventive and targeted healthcare solutions. Increased adoption of biologics and specialized monoclonal antibodies for companion animals is becoming more common, while livestock healthcare is increasingly supported by modern vaccine technologies and herd-level disease prevention strategies. Personalized veterinary medicine is also gaining traction as diagnostic capabilities and biomarker-based testing become more widely available, allowing veterinarians to customize treatments based on species characteristics and specific health conditions. Furthermore, the development of patient-friendly therapeutic options is expanding treatment possibilities beyond conventional medication methods.
The veterinary services segment held a 74.5% share in 2025 and is projected to grow at a CAGR of 6% throughout 2035. This strong market performance is largely driven by increasing disposable income levels and rising demand for professional veterinary care. Growing awareness about animal health and well-being has encouraged more individuals to seek comprehensive veterinary services for their animals. In addition, advancements in veterinary medical technologies have expanded the scope of services available within the sector. A wide range of pet-focused services has become more accessible, supporting higher utilization of veterinary facilities. The integration of modern healthcare technologies and improved service offerings is strengthening the overall veterinary services segment and supporting continued market expansion.
The companion animals segment generated USD 133.1 billion in 2025. This segment is categorized into several groups within the broader companion animal population. Rising global adoption of animals as household companions is a major factor supporting the growth of this segment. A significant portion of households worldwide currently care for animals as companions, contributing to increased demand for veterinary care, medical products, and specialized healthcare services. Higher spending on pet health and wellness is also encouraging the development and introduction of innovative animal healthcare solutions. In addition, growing disposable income levels in emerging economies are enabling more pet owners to invest in advanced healthcare products and veterinary services, further supporting the expansion of the companion animals segment.
North America Animal Healthcare Market held a 38.5% share in 2025. The region maintains a leading position due to its well-established veterinary healthcare infrastructure and widespread adoption of advanced medical solutions for animal care. Strong utilization of innovative therapeutics, vaccines, and parasite control products across both companion animal and livestock populations contributes to regional market growth. North America also benefits from the early implementation of advanced diagnostic technologies and precision veterinary healthcare approaches. The presence of major industry participants with strong research and development capabilities further accelerates innovation within the region. Growing awareness of preventive animal healthcare, along with increasing concern regarding chronic and zoonotic diseases affecting animals, continues to drive demand for advanced veterinary services and premium animal health products.
Key companies operating in the Global Animal Healthcare Market include Zoetis, Merck, Boehringer Ingelheim, Elanco Animal Health, Virbac, Vetoquinol, Ceva Sante Animale, Dechra Pharmaceuticals, IDEXX Laboratories, Phibro Animal Health, Neogen, HIPRA, B. Braun Vet Care (B Braun Melsungen), Symrise, Sklar Surgical Instruments, Medtronic, Endovac Animal Health, Indian Immunologicals, Kyoritsu Seiyaku, and Ourofino Saude Animal. Companies active in the Animal Healthcare Market are implementing several strategic approaches to strengthen their competitive position and expand their global footprint. A key focus area is investment in research and development aimed at introducing innovative veterinary pharmaceuticals, vaccines, and diagnostic technologies. Many organizations are also expanding their product portfolios through strategic partnerships, acquisitions, and collaborations with biotechnology firms and veterinary research institutions. Geographic expansion into emerging markets is another important strategy, as companies seek to capture rising demand for animal health products in developing regions. In addition, firms are enhancing digital capabilities by integrating data-driven diagnostics, tele-veterinary services, and advanced monitoring technologies into their offerings. Companies are also prioritizing sustainable production practices and regulatory compliance to maintain product credibility while supporting long-term growth in the animal healthcare market.
Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research approach
1.3 Quality commitments
1.3.1 GMI AI policy and data integrity commitment
1.3.1.1 Source consistency protocol
1.4 Research trail and confidence scoring
1.4.1 Research trail components
1.4.2 Scoring components
1.5 Data collection
1.5.1 Partial list of primary sources
1.6 Data mining sources
1.6.1 Paid sources
1.6.1.1 Sources, by region
1.7 Base estimates and calculations
1.7.1 Revenue share analysis
1.7.2 Base year calculation
1.8 Forecast model
1.9 Research transparency addendum
1.9.1 Source attribution framework
1.9.2 Quality assurance metrics
1.9.3 Our commitment to trust
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
2.2 Key market trends
2.2.1 Regional trends
2.2.2 Product trends
2.2.3 Animal type trends
2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing population of pet animals
3.2.1.2 Increasing support offered by government and public organizations for animal care
3.2.1.3 Growing demand for online veterinary pharmacies
3.2.1.4 Increase in animal healthcare expenditure
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost associated with animal health drugs
3.2.2.2 Limited access in rural areas
3.2.3 Market opportunities
3.2.3.1 Expansion of telemedicine and remote veterinary consultation
3.2.3.2 Rising adoption of preventive and wellness-focused animal health solutions
3.3 Growth potential analysis
3.4 Technology landscape (Driven by Primary Research)
3.4.1 Current technological trends
3.4.2 Emerging technologies
3.5 Regulatory landscape (Driven by Primary Research)
3.5.1 North America
3.5.2 Europe
3.5.3 Asia Pacific
3.5.4 Latin America
3.5.5 Middle East and Africa
3.6 Reimbursement scenario (Driven by Primary Research)
3.7 Venture capitalist scenario in animal health industry
3.8 Economic impacts of the animal health industry
3.9 Consumer behaviour trends (Driven by Primary Research)
3.10 Future market trends (Driven by Primary Research)
3.11 Impact of AI and generative AI on the market
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
4.6.1 Merger and acquisition
4.6.2 Partnership and collaboration
4.6.3 New product launches
4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)
5.1 Key trends
5.2 Pharmaceuticals
5.2.1 Type
5.2.1.1 Drugs
5.2.1.1.1 Antiparasitic
5.2.1.1.2 Anti-inflammatory
5.2.1.1.3 Anti-infectives
5.2.1.1.4 Corticosteroids
5.2.1.1.5 Tranquilizers
5.2.1.1.6 Cardiovascular drugs
5.2.1.1.7 Gastrointestinal drugs
5.2.1.1.8 Other drugs
5.2.1.2 Vaccines
5.2.1.2.1 Modified live vaccines (MLV)
5.2.1.2.2 Killed inactivated vaccines
5.2.1.2.3 Other vaccines
5.2.1.3 Medicated feed additives
5.2.1.3.1 Antibiotics
5.2.1.3.2 Vitamins
5.2.1.3.3 Amino acids
5.2.1.3.4 Enzymes
5.2.1.3.5 Antioxidants
5.2.1.3.6 Prebiotics and probiotics
5.2.1.3.7 Minerals
5.2.1.3.8 Other medicated feed additives
5.2.2 Indication
5.2.2.1 Dermatology
5.2.2.2 Cardiovascular diseases
5.2.2.3 Gastrointestinal diseases
5.2.2.4 Respiratory diseases
5.2.2.5 Other indications
5.2.3 Distribution channel
5.2.3.1 Veterinary hospital pharmacies
5.2.3.2 E-commerce
5.2.3.3 Retail pharmacies
5.3 Medical devices
5.3.1 Veterinary diagnostic equipment
5.3.2 Anesthesia equipment
5.3.3 Patient monitoring equipment
5.3.4 Veterinary surgical equipment
5.3.5 Veterinary consumables
5.3.6 Other medical devices
5.4 Veterinary services
Chapter 6 Market Estimates and Forecast, By Animal Type, 2022 - 2035 ($ Mn)
6.1 Key trends
6.2 Companion animals
6.2.1 Dogs
6.2.2 Cats
6.2.3 Horses
6.2.4 Other companion animals
6.3 Livestock animals
6.3.1 Poultry
6.3.2 Swine
6.3.3 Cattle
6.3.4 Fish
6.3.5 Other livestock animals
Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 Australia
7.4.5 South Korea
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 GCC Countries
7.6.3 Israel
Chapter 8 Company Profiles
8.1 B. Braun Vet Care (B Braun Melsungen)
8.2 Boehringer Ingelheim
8.3 Ceva Sante Animale
8.4 Dechra Pharmaceuticals
8.5 Elanco Animal Health
8.6 Endovac Animal Health
8.7 HIPRA
8.8 IDEXX Laboratories
8.9 Merck
8.10 Medtronic
8.11 Neogen
8.12 Sklar Surgical Instruments
8.13 Symrise
8.14 Vetoquinol
8.15 Virbac
8.16 Zoetis
8.17 Phibro Animal Health
8.18 Indian Immunologicals
8.19 Kyoritsu Seiyaku
8.20 Ourofino Saude Animal
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.